The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

Green, A. Richard, Mechan, Annis O., Elliott, J. Martin, O’Shea, Esther, Colado, M. Isabel·2003·Pharmacological Reviews

Cited by (1,000)

Items 701–800 of 1,000

  1. MDMA & Cannabis: A Mini-Review of Cognitive, Behavioral, and Neurobiological Effects of Co-Consumption
    Sybille Schulz · 2011 · Current Drug Abuse Reviews
  2. Gender differences in hyperthermia and regional 5-HT and 5-HIAA depletion in the brain following MDMA administration in rats
    Alinde E. Wallinga, Carolin Grahlmann, Ramon A. Granneman, Jaap M. Koolhaas, Bauke Buwalda · 2011 · Brain Research
  3. Attenuation of MDMA-induced hyperthermia by ethanol in rats depends on ambient temperature
    Jean‐Christophe Cassel, Sami Ben Hamida, Byron C. Jones · 2007 · European Journal of Pharmacology
  4. Age differences in (±) 3,4‐methylenedioxymethamphetamine (MDMA)‐induced conditioned taste aversions and monoaminergic levels
    Jennifer L. Cobuzzi, Kayla A. Siletti, Zachary E. Hurwitz, Bradley Wetzell, Michael H. Baumann, Anthony Lee Riley · 2013 · Developmental Psychobiology
  5. Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors
    Luisa Ponzoni, Daniela Braida, Mariaelvina Sala · 2016 · Psychopharmacology
  6. S(+)- and R(−)N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) as discriminative stimuli: Effect of cocaine
    Tatiana S Bondareva, Anna Wesołowska, Maƚgorzata Dukat, Mase Lee, Richard Young, Richard A. Glennon · 2005 · Pharmacology Biochemistry and Behavior
  7. 3,4-Methylenedioxymethamphetamine increases neuropeptide messenger RNA expression in rat striatum
    David H. Adams, Glen R. Hanson, Kristen A. Keefe · 2004 · Molecular Brain Research
  8. Apparent Transient Effects of Recent ???Ecstasy??? Use on Cognitive Performance and Extrapyramidal Signs in Human Subjects
    Ryan M. Smith, Madalina E. Tivarus, Heather Campbell, Ashleigh J. Hillier, David Quentin Beversdorf · 2006 · Cognitive and Behavioral Neurology
  9. Tumour necrosis factor alpha suppression by MDMA is mediated by peripheral heteromeric nicotinic receptors
    Jorge Camarasa, Clara Ros, David Pubill, Elena Escubedo · 2010 · Immunopharmacology and Immunotoxicology
  10. The acute and long-term neurotoxic effects of MDMA on marble burying behaviour in mice
    Kathryn S. Saadat, J. Martin Elliott, M. Isabel Colado, A. Richard Green · 2006 · Journal of Psychopharmacology
  11. Actions of MDMA at glutamatergic neuromuscular junctions
    Garrett M. Sparks, Sameera Dasari, Robin Lewis Cooper · 2004 · Neuroscience Research
  12. Environmentally Friendly Expeditious One-Pot Electrochemical Synthesis of Bis-Catechol-Thioether Metabolites of Ecstasy: in vitro Neurotoxic Effects in the Rat Hippocampus
    Anne Felim, Anne Neudörffer, François P. Monnet, Martine Largeron · 2008 · International Journal of Electrochemical Science
  13. Increased anxiety-related behavior in male and female adult rats following early and late adolescent exposure to 3,4-methylenedioxymethamphetamine (MDMA)
    Olga V. Kolyaduke, Robert N. Hughes · 2012 · Pharmacology Biochemistry and Behavior
  14. fNIRS suggests increased effort during executive access in ecstasy polydrug users
    Carl Alexander Roberts, Catharine Montgomery · 2014 · Psychopharmacology
  15. Repeated administration of the 5-HT1B/1A agonist, RU 24969, facilitates the acquisition of MDMA self-administration: role of 5-HT1A and 5-HT1B receptor mechanisms
    Dane Aronsen, Natasha Bukholt, Susan Schenk · 2016 · Psychopharmacology
  16. Gene expression analysis indicates reduced memory and cognitive functions in the hippocampus and increase in synaptic reorganization in the frontal cortex 3 weeks after MDMA administration in Dark Agouti rats
    Péter Petschner, Viola Tamási, Csaba Ádori, Eszter Kirilly, Rómeó D. Andó, László Tóthfalusi, György Bagdy · 2018 · BMC Genomics
  17. Chronic ecstasy use increases neurotrophin-4 gene expression and protein levels in the rat brain
    Homeira Hatami, Mohammad Ali Hossainpour-Faizi, Maryam Azarfarin, Parvin Azarfam · 2010 · Pharmacological Reports
  18. Regulation of opioid gene expression in the rat brainstem by 3,4-methylenedioxymethamphetamine (MDMA): role of serotonin and involvement of CREB and ERK cascade
    Manuela Di Benedetto, Sussy Bastias Candia, Claudio D’Addario, Elena Elettra Porticella, Chiara Cavina, Sanzio Candeletti, Patrizia Romualdi · 2010 · Naunyn-Schmiedeberg s Archives of Pharmacology
  19. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
    Eszter Kirilly · 2010 · PubMed
  20. Analysis of MDMA and its Metabolites in Urine and Plasma Following a Neurotoxic Dose of MDMA
    Sandra Valtier, Clyde F. Phelix, John T. Cody · 2007 · Journal of Analytical Toxicology
  21. Redesigning the designer drug ecstasy: non-psychoactive MDMA analogues exhibiting Burkitt's lymphoma cytotoxicity
    Michael N. Gandy, Matthew J. McIldowie, Katie D. Lewis, Agata Magdalena Wasik, Danielle Salomonczyk, Keith Wagg, Zak A. Millar, David Tindiglia, Philippe Huot, Tom H. Johnston et al. · 2010 · MedChemComm
  22. Topiramate prevents ecstasy consumption: a case report
    Shahin Akhondzadeh, Ali Daliri Hampa · 2005 · Fundamental and Clinical Pharmacology
  23. Bioisosteric analogs of MDMA : Improving the pharmacological profile?
    Ana Sofia Alberto‐Silva, Selina Hemmer, Hailey A. Bock, Letícia Alves da Silva, Kenneth R. Scott, Nina Kastner, Manan Bhatt, Marco Niello, Kathrin Jäntsch, Oliver Kudlacek et al. · 2024 · Journal of Neurochemistry
  24. MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used ‘Ecstasy’ during pregnancy
    Andrew C. Parrott, Derek G. Moore, John J. Turner, Julia E. Goodwin, Meeyoung Oh Min, Lynn T. Singer · 2014 · Human Psychopharmacology Clinical and Experimental
  25. Metabolic interactions between ethanol and MDMA in primary cultured rat hepatocytes
    Helena Pontes, Paula Guedes de Pinho, Eduarda G. R. Fernandes, Paula S. Branco, Luísa Maria Ferreira, Helena Carmo, Fernando Remião, Félix Dias Carvalho, Maria de Lourdes Bastos · 2010 · Toxicology
  26. The Role of Serotonin in Drug Addiction
    Christian P. Müller, Martin E. Pum, Günter Schumann, Joseph P. Huston · 2010 · Handbook of behavioral neuroscience
  27. Influence of chronic caffeine on MDMA-induced behavioral and neuroinflammatory response in mice
    Jéssica Ruiz‐Medina, Ana Xavier Pinto, Marta Rodríguez‐Arias, José Miñarro, Olga Valverde · 2012 · Psychopharmacology
  28. Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing
    Tristan J. Watkins, Vidya Raj, Junghee Lee, Mary S. Dietrich, Aize Cao, Jennifer Urbano Blackford, Ronald M. Salomon, Sohee Park, Margaret M. Benningfield, Christina Iorio et al. · 2012 · Psychopharmacology
  29. The Identification of a Chlorinated MDMA
    V. Marešová, J. Hampl, Z. Chundela, Frantisek Zrcek, Miroslav Polášek, Jirí Chadt · 2005 · Journal of Analytical Toxicology
  30. Acute behavioral effects of co-administration of mephedrone and MDMA in mice
    Barbara Budzyńska, Agnieszka Michalak, Małgorzata Frankowska, Katarzyna Kaszubska, Grażyna Biała · 2016 · Pharmacological Reports
  31. MDMA toxicity: management of acute and life-threatening presentations
    Nicola Davies, William English, Johann Gründlingh · 2018 · British Journal of Nursing
  32. The drug purity discounting task: Ecstasy use likelihood is reduced by probabilistic impurity according to harmfulness of adulterants
    Sean B. Dolan, Matthew W. Johnson · 2020 · Drug and Alcohol Dependence
  33. Êxtase (MDMA): efeitos farmacológicos e tóxicos, mecanismo de ação e abordagem clínica
    Caroline Addison Carvalho Xavier, Patrícia Leal Dantas Lobo, Marta Maria de França Fonteles, Silvânia Maria Mendes Vasconcelos, Glauce Socorro de Barros Viana, Francisca Cléa Florenço de Sousa · 2008 · Archives of Clinical Psychiatry (São Paulo)
  34. Sustained Exposure to 3,4-Methylenedioxymethamphetamine Induces the Augmentation of Exocytotic Serotonin Release in Rat Organotypic Raphe Slice Cultures
    Kazuki Nagayasu, Maiko Kitaichi, Hisashi Shirakawa, Takayuki Nakagawa, Shuji Kaneko · 2010 · Journal of Pharmacological Sciences
  35. Glucose and corticosterone changes in developing and adult rats following exposure to (±)-3,4-methylendioxymethamphetamine or 5-methoxydiisopropyltryptamine
    Devon L. Graham, Nicole R. Herring, Tori L. Schaefer, Charles V. Vorhees, Michael T. Williams · 2009 · Neurotoxicology and Teratology
  36. High-dose MDMA does not result in long-term changes in impulsivity in the rat
    Kathryn S. Saadat, J. Elliott, A. Green, P. Moran · 2006 · Psychopharmacology
  37. Amphétamines et dérivés
    Marie-Hélène Ghysel · 2004 · EMC - Toxicologie-Pathologie
  38. Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”) administration in awake rats
    Jan Bert Gramsbergen, Paul D. Cumming · 2007 · Neurochemistry International
  39. Absorption and clearance of ±3,4-methylenedioxymethamphetamine from the plasma of neonatal rats
    Michael T. Williams, Carrie A. Brown, Matthew R. Skelton, Alexander A. T. M. M. Vinks, Charles V. Vorhees · 2004 · Neurotoxicology and Teratology
  40. Studies on the mechanisms underlying amiloride enhancement of 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats
    Beatriz Goñi‐Allo, Elena Puerta, Isabel Hervías, Richard Di Palma, María Ramos, Berta Lasheras, Norberto Aguirre · 2007 · European Journal of Pharmacology
  41. A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder
    Benjamin R. Lewis, Kevin Byrne · 2023 · FOCUS The Journal of Lifelong Learning in Psychiatry
  42. Inhibition of 3,4‐methylenedioxymethamphetamine metabolism leads to marked decrease in 3,4‐dihydroxymethamphetamine formation but no change in serotonin neurotoxicity: Implications for mechanisms of neurotoxicity
    Melanie Mueller, Jie Yuan, Concepción Maldonado Adrián, Una D. McCann, George A. Ricaurte · 2011 · Synapse
  43. D1 but not D4 Dopamine Receptors are Critical for MDMA-Induced Neurotoxicity in Mice
    Noelia Granado, Sara Ares‐Santos, Rosario Moratalla · 2013 · Neurotoxicity Research
  44. Psychotomimetic effects of PCP, LSD, and Ecstasy: pharmacological models of schizophrenia?
    Vibeke Sorensen Catts, Stanley Victor Catts · 2010 · Cambridge University Press eBooks
  45. Subacute effects of ecstasy on mood: an exploration of associated risk factors
    Rebecca M. Scott, Leanne M. Hides, Janice Sabura Allen, Dan Ian Lubman · 2012 · Journal of Psychopharmacology
  46. 3,4-Methylenedioxymethamphetamine (Ecstasy) Decreases Inflammation and Airway Reactivity in a Murine Model of Asthma
    Daniel Stankevicius, V. Ferraz-de-Paula, Alison Ribeiro, M.L. Pinheiro, Ana Paula Ligeiro de Oliveira, Amílcar Sabino Damazo, Silvio Fernandes Lapachinske, Regina L. M. Moreau, Wothan Tavares de Lima, João Palermo‐Neto · 2012 · NeuroImmunoModulation
  47. Behavioral profiles in rats distinguish among “ecstasy,” methamphetamine and 2,5-dimethoxy-4-iodoamphetamine: Mixed effects for “ecstasy” analogues.
    David Quinteros-Muñoz, Patricio Sáez‐Briones, Gabriela Díaz‐Véliz, Sergio Mora-Gutiérrez, Marco Rebolledo-Fuentes, Bruce K. Cassels · 2010 · Behavioral Neuroscience
  48. Direct Analysis of Conjugate Metabolites of Methamphetamine, 3,4-Methylenedioxymethamphetamine, and Their Designer Drugs in Biological Fluids
    Noriaki Shima, Munehiro Katagi, Hitoshi Tsuchihashi · 2009 · Eisei kagaku
  49. Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251
    Yoko Nawata, Kiyoyuki Kitaichi, Tsuneyuki Yamamoto · 2015 · Drug and Alcohol Dependence
  50. MDMA decreases glutamic acid decarboxylase (GAD) 67-immunoreactive neurons in the hippocampus and increases seizure susceptibility: Role for glutamate
    Courtney Huff, Rachel L. Morano, James P. Herman, Bryan K. Yamamoto, Gary A. Gudelsky · 2016 · NeuroToxicology
  51. Binge-like acquisition of α-pyrrolidinopentiophenone (α-PVP) self-administration in female rats
    Mehrak Javadi Paydar, Eric L. Harvey, Yanabel Grant, Sophia A. Vandewater, Kevin M. Creehan, Jacques D. Nguyen, Tobin J. Dickerson, Michael A. Taffe · 2018 · Psychopharmacology
  52. Combining ecstasy and ethanol: higher risk for toxicity? A review
    Eefje Vercoulen, Laura Hondebrink · 2021 · Critical Reviews in Toxicology
  53. Serotonin transporter availability, neurocognitive function and their correlation in abstinent 3,4‐methylenedioxymethamphetamine users
    Foke L. van de Blaak, Glenn Dumont · 2021 · Human Psychopharmacology Clinical and Experimental
  54. Cannabis Use Disorders
    Perry M. Duncan · 2020 · Cambridge University Press eBooks
  55. ACUTE HIPPOCAMPAL SCLEROSIS FOLLOWING ECSTASY INGESTION
    Helen Gardner, Nicholas D. Lawn, Daniel M Fatovich, John S. Archer · 2009 · Neurology
  56. Effets aigus et à long terme de l’ecstasy
    Julie Salzmann, Cynthia Marie-claire A, Florence Noble · 2004 · La Presse Médicale
  57. Ecstasy versus alcohol: Tolstoy and the variations of unhappiness
    Andrew C. Parrott · 2007 · Journal of Psychopharmacology
  58. Occurrence, source, and ecological risk of pharmaceuticals and illicit drugs in surface water in Las Vegas, USA
    Douglas B. Sims, Jenny Monk, Mark C. Garner, Amanda C. Hudson, J. E. Keller, Cristina Aguaiza, Kazumasa Lindley, Demessew Alemu Woldetsadik, Andressa Cristhy Buch · 2024 · International Journal of Environmental Science and Technology
  59. 5,7-Dihydroxitryptamine toxicity to serotonergic neurons in serum free raphe cultures
    João Paulo Capela, Marion M. Lautenschlager, Ulrich Dirnagl, Maria de Lourdes Bastos, Félix Dias Carvalho, Andreas Meisel · 2008 · European Journal of Pharmacology
  60. Effects of repeated exposure to MDMA on 5HT1a autoreceptor function: behavioral and neurochemical responses to 8-OHDPAT
    Susan Schenk, Blaine Abraham, Dane Aronsen, Joyce Colussi‐Mas, Jennifer Do · 2013 · Psychopharmacology
  61. Non-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma Cells
    Dina Popova, Andréas Forsblad, Sanaz Hashemian, Stig O. P. Jacobsson · 2016 · PLoS ONE
  62. Comparison of the effects of abstinence on MDMA and cocaine self-administration in rats
    Quenten Highgate, Susan Schenk · 2018 · Psychopharmacology
  63. A convenient biomimetic synthesis of optically active putative neurotoxic metabolites of MDMA (“ecstasy”) from R-(−)- and S-(+)-N-methyl-α-methyldopamine precursors
    Claire-Marie Martinez, Anne Neudörffer, Martine Largeron · 2012 · Organic & Biomolecular Chemistry
  64. MDMA (Ecstasy) Decreases the Number of Neurons and Stem Cells in Embryonic Cortical Cultures
    Anna M. S. Kindlundh-Högberg, Chris Pickering, Grzegorz Wicher, David Hobér, Helgi B. Schiöth, Åsa Fex Svenningsen · 2009 · Cellular and Molecular Neurobiology
  65. Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users
    Kelly Allott, BJ Canny, Jillian Helen Broadbear, Nigel K. Stepto, Brendán Murphy, Jennifer R. Redman · 2008 · Journal of Psychopharmacology
  66. Interactions between 3,4-Methylenedioxymethamphetamine and Ethanol in Humans and Rodents
    Wael M.Y. Mohamed, Sami Ben Hamida, Anne Pereira de Vasconcelos, Jean‐Christophe Cassel, Byron C. Jones · 2009 · Neuropsychobiology
  67. Attenuation of the disruptive effects of (+/-)3,4-methylenedioxymethamphetamine and cocaine on delayed matching-to-sample performance with D1 versus D2 antagonists
    David N. Harper · 2011 · Addiction Biology
  68. Understanding the Contribution of Individual Amino Acid Residues in the Binding of Psychoactive Substances to Monoamine Transporters
    Tamara Senior, Michelle J. Botha, Alan Robert Kennedy, Jesus Calvo‐Castro · 2020 · ACS Omega
  69. Effects of MDMA on the Human Nervous System
    Una D. McCann, George A. Ricaurte · 2014 · Elsevier eBooks
  70. Drogen- und Medikamentenabhängigkeit
    Torsten Kienast, Andreas Heinz, M. Soyka · 2011 · Springer eBooks
  71. Sleep Deprivation Differentially Impairs Cognitive Performance in Abstinent Methylenedioxymethamphetamine (“Ecstasy”) Users
    Una D. McCann, Michael John Wilson, Francis P. Sgambati, George A. Ricaurte · 2009 · Journal of Neuroscience
  72. Acute Neurochemical and Behavioral Effects of Stereoisomers of 4-Methylaminorex in Relation to Brain Drug Concentrations
    Aino Kankaanpää, Satu Ellermaa, Esa Meririnne, Paula Hirsjärvi, Timo Seppälä · 2002 · Journal of Pharmacology and Experimental Therapeutics
  73. Effects of long-term exposure of 3,4-methylenedioxymethamphetamine (MDMA; “ecstasy”) on neuronal transmitter transport, brain immuno-regulatory systems and progression of experimental periodontitis in rats
    Torbjørn Jarle Breivik, Inger Lise Bogen, Kristin Huse Haug, Frode Fonnum, Per-Kristian Opstad, Dag M. Eide, Oddvar Myhre · 2014 · Neurochemistry International
  74. Neurochemical and behavioural characterisation of alkoxyamphetamine derivatives in rats
    Cesar A. Romero, Diego A. Bustamante, Gerald Zapata‐Torres, Michel Goiny, Bruce K. Cassels, Mario Herrera‐Marschitz · 2006 · Neurotoxicity Research
  75. Memory impairment induced by amphetamine derivatives in laboratory animals and in humans: a review
    Jordi Camarasa, Teresa Rodrigo, David Pubill, Elena Escubedo · 2011 · BioMolecular Concepts
  76. Acute MDMA administration alters the distribution and circadian rhythm of wheel running activity in the rat
    Rowan P. Ogeil, Shantha M. W. Rajaratnam, Jennifer R. Redman, Jillian Helen Broadbear · 2010 · Brain Research
  77. Rewarding effects of 3,4-methylenedioxymethamphetamine (“Ecstasy”) in dominant and subordinate OF-1 mice in the place preference conditioning paradigm
    Gabriel Rodríguez-Alarcón, Juan J. Canales, Alicia Salvador · 2006 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  78. Development of murine monoclonal antibodies to methamphetamine and methamphetamine analogues
    Yannic Danger, Caroline Gadjou, Anne Devys, Hervé Galons, Dominique Blanchard, Gilles Folléa · 2005 · Journal of Immunological Methods
  79. Sigma 1 Receptor Chaperone: Pharmacology and Therapeutic Perspectives
    Daniel Zamanillo, Enrique F. Portillo-Salido, José Miguel Vela, Luz I. Romero · 2012
  80. RETRACTED ARTICLE: Gene expression analysis indicates CB1 receptor upregulation in the hippocampus and neurotoxic effects in the frontal cortex 3 weeks after single-dose MDMA administration in Dark Agouti rats
    Péter Petschner, Viola Tamási, Csaba Ádori, Eszter Kirilly, Rómeó D. Andó, László Tóthfalusi, György Bagdy · 2013 · BMC Genomics · Retracted
  81. Effects of chronic intracerebroventricular 3,4-methylenedioxy-N-methamphetamine (MDMA) or fluoxetine on the active avoidance test in rats with or without exposure to mild chronic stress
    Laura Andrea León, J. Landeira-Fernández, Fernando P. Cárdenas · 2009 · Behavioural Brain Research
  82. State-dependent and environmental modulation of brain hyperthermic effects of psychoactive drugs of abuse
    Eugene A. Kiyatkin · 2014 · Temperature
  83. Blockade of noradrenaline transport abolishes 4‐methylthioamphetamine‐induced contraction of the rat aortain vitro
    Sinéad Quinn, Patrick J. Guiry, T. Schwab, ALAN K. KEENAN, Gethin J. McBean · 2006 · Autonomic and Autacoid Pharmacology
  84. Self-reports of Executive Dysfunction in Current Ecstasy/Polydrug Users
    Florentia Hadjiefthyvoulou, John E. Fisk, Catharine Montgomery, Nikola Bridges · 2012 · Cognitive and Behavioral Neurology
  85. Increased effects of 3,4-methylenedioxymethamphetamine (ecstasy) in a rat model of depression
    Emily Joy Jaehne, Irina Majumder, Abdallah Salem, Rodney James Irvine · 2010 · Addiction Biology
  86. Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine (“Ecstasy”) induced cytoskeletal damage
    Francesco Bavato, Serena Stamatakos, Cristine Marie Yde Ohki, Erich Seifritz, Patrizia Romualdi, Edna Grünblatt, Boris B. Quednow · 2022 · Journal of Neural Transmission
  87. Association of paradoxical sleep deprivation and ecstasy (MDMA) enhances genital reflexes in male rats
    Mônica L. Andersen, Juliana C. Perry, Murilo Campos Battisti, Mariana Bendlin Calzavara, José Luiz Costa, O.N. Neto, Roberto Frussa‐Filho, Sergio Brasil Tufik · 2006 · Behavioural Brain Research
  88. Effects of 3,4-Methylenedioxymethamphetamine Administration on Retinal Physiology in the Rat
    João Martins, Miguel S. Castelo-Branco, Ana Batista, Bárbara Oliveiros, Ana Raquel Santiago, Joana Galvão, Eduarda G. R. Fernandes, Félix Dias Carvalho, Cláudia Cavadas, António Francisco Ambrósio · 2011 · PLoS ONE
  89. In vitro neuronal and vascular responses to 5-hydroxytryptamine: modulation by 4-methylthioamphetamine, 4-methylthiomethamphetamine and 3,4-methylenedioxymethamphetamine
    James E. Murphy, James Flynn, Dara M. Cannon, Patrick J. Guiry, Peter McCormack, Alan W. Baird, Gethin J. McBean, ALAN K. KEENAN · 2002 · European Journal of Pharmacology
  90. Drug‐related harm: a complex and difficult concept to scale
    Andrew C. Parrott · 2007 · Human Psychopharmacology Clinical and Experimental
  91. Acute tryptophan depletion potentiates 3,4‐methylenedioxymethamphetamine‐induced cerebrovascular hyperperfusion in adult male wistar rats
    Eva L. van Donkelaar, Paul A.T. Kelly, Neil Dawson, Arjan Blokland, Jos Prickaerts, Harry W.M. Steinbusch, Linda Ferrington · 2009 · Journal of Neuroscience Research
  92. Caffeine alters the behavioural and body temperature responses to mephedrone without causing long-term neurotoxicity in rats
    Sinead E. Shortall, A. Richard Green, Kevin C.F. Fone, Madeleine V. King · 2016 · Journal of Psychopharmacology
  93. MDMA, Methylone, and MDPV: Drug-Induced Brain Hyperthermia and Its Modulation by Activity State and Environment
    Eugene A. Kiyatkin, Suelynn E. Ren · 2016 · Current topics in behavioral neurosciences
  94. 3,4-Methylenedioxymethamphetamine (MDMA) Alters Synaptic Dopamine Release in the Dorsal Striatum Through Nicotinic Receptors and DAT Inhibition
    Francesca Romana Rizzo, Mauro Federici, Nicola Biagio Mercuri · 2018 · Neuroscience
  95. Management of cardiogenic shock by circulatory support during reverse Tako-Tsubo following amphetamine exposure: A report of two cases
    Pierre-Antoine Cotinet, Philippe Bizouarn, François Roux, Bertrand R Rozec · 2020 · Heart & Lung
  96. Analgesic and behavioral effects of amphetamine enantiomers, p-methoxyamphetamine and n-alkyl-p-methoxyamphetamine derivatives
    Diego Bustamante, Gabriela Díaz‐Véliz, Carlos Paeile, Gerald Zapata‐Torres, Bruce K. Cassels · 2004 · Pharmacology Biochemistry and Behavior
  97. Ecstasy (3,4-methylenedioxymethamphetamine) limits murine gammaherpesvirus-68 induced monokine expression
    Daniel A. Nelson, Jamie L. Nirmaier, Sam J. Singh, Melanie D. Tolbert, Kenneth L. Bost · 2008 · Brain Behavior and Immunity
  98. (±)3,4-Methylenedioxyamphetamine elicits action potential bursts in a central snail neuron
    Ming-Cheng Tsai, Yi‐Hung Chen · 2006 · Experimental Neurology
  99. Psychoactive substances for the treatment of neuropsychiatric disorders
    Zifan Zhen, Xueqiang Sun, Shiying Yuan, Jiancheng Zhang · 2024 · Asian Journal of Psychiatry
  100. The effects of psychedelic-assisted therapy on illness and death anxiety: A systematic review and meta-analysis
    Aron Amaev, Jianmeng Song, Yasaman Kambari, Edgardo Carmona-Torres, Ali Abdolizadeh, Fumihiko Ueno, Teruki Koizumi, Antonio P. Strafella, Muhammad Ishrat Husain, Ariel Graff‐Guerrero et al. · 2025 · Journal of Psychiatric Research